A major change in the insurance coverage of subsidised cancer patients took effect on Sept 1, 2022. The same change will apply to private patients on Integrated Shield Plans (IPs) from April 1, 2023.
MediShield Life and IPs can no longer cover all cancer treatments, only those proven to work. This, too, on the condition that the drug provides value for money.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
